JAMA Network
About The Study: The results of this meta-analysis of 286 randomized clinical trials including 9,500 patients suggest that Black and Hispanic men are underrepresented in trials compared with their share of prostate cancer incidence. The representation of Black patients has consistently remained low during the past 2 decades.
Authors: Irbaz Bin Riaz, M.B.B.S., M.S., of Harvard Medical School in Boston, is the corresponding author.
To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/
(doi:10.1001/jamaoncol.2022.5511)
/Public Release. This material from the originating organization/author(s) might be of the point-in-time nature, and edited for clarity, style and length. Mirage.News does not take institutional positions or sides, and all views, positions, and conclusions expressed herein are solely those of the author(s).View in full here.
